PriceSensitive

Nextleaf (CSE:OILS) launches THC Softgels in British Columbia and awarded its 19th U.S. patent

Cannabis
CSE:OILS
03 November 2022 12:30 (EDT)

Nextleaf (OILS) has delivered its initial purchase order from the B.C. Liquor and Distribution Branch for Glacial Gold THC 10mg Softgels.

The first Glacial Gold THC 10mg Softgels to launch is a 50-pack large format size. It is now available for B.C. retailers to order. Nextleaf is introducing a 10-pack trial size of Glacial Gold THC 10mg Softgels in the coming weeks. This is to address the market for edible cannabis products with more THC per package.

The company is positioning its 10-pack trial size of Glacial Gold THC 10mg Softgels to disrupt the edible market. It provides savings of over 75 per cent (price per milligram) for adult consumers compared to the value edible category.

The softgels are made with high-purity cannabis distillate in a base of organic coconut MCT oil. It is expertly encapsulated for a premium consumer experience without premium pricing.

Nextleaf also announced that the United States Patent and Trademark Office has granted the company its 19th-issued U.S. patent. The company’s latest U.S. patent describes a second proprietary method in which spent cannabis and hemp biomass is heated in stages to reclaim residual cannabinoids while simultaneously generating carbon with the desired porosity level (“activated carbon”).

When utilized, this patented process allows Nextleaf to maximize its cannabinoid yield. It allows Nextleaf to reduce waste destined for landfills and further protect a potential future business vertical at a minimal cost. The company owns one of the largest collections of U.S. patents among all cannabis companies. 

Nextleaf manufactures and distributes cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold.

Nextleaf Solutions Ltd. (OILS) remains steady, trading at C$0.065 per share at 12:19 pm ET.


Related News